Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 91

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 91
---
 an internet website that contains reports and other information about
issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.

<div align='center'>26</div>

We are a “foreign private issuer”
as defined in Rule 3b-4 under the Securities Exchange Act of 1934, or the Exchange Act. As a result, our proxy solicitations are
not subject to the disclosure and procedural requirements of Regulation 14A under the Exchange Act and transactions in our equity securities
by our officers and directors are exempt from Section 16 of the Exchange Act. In addition, we are not required under the Exchange
Act to file periodic reports and financial statements as frequently or as promptly as U.S. companies whose securities are registered
under the Exchange Act. We publish annually an annual report filed on Form 20-F containing financial statements that have been examined
and reported on, with an opinion expressed by, a registered public accounting firm. We prepare our annual financial statements in United
States dollars and in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. If there is any inconsistency
between the information in this prospectus and in any post-effective amendment to the Form F-3 of which this prospectus is a part,
or in any prospectus supplement, you should rely on the information in the post-effective amendment or prospectus supplement, as relevant.
You should read this prospectus and any post-effective amendment or prospectus supplement together with the additional information contained
in documents listed above under the heading “Where You Can Find More Information; Incorporation of Information by Reference.”
The registration statement containing this prospectus, including the exhibits to the registration statement, provides additional information
about us, the securities offered under this prospectus, and our other outstanding securities. The registration statement, including the
exhibits, can be read at the SEC’s website mentioned above under “Where You Can Find More Information; Incorporation of Information
by Reference.”

We will provide to each person, including any
beneficial owner, to whom this prospectus is delivered, a copy of any or all the information that has been incorporated by reference
in this prospectus but not delivered with this prospectus (and any exhibits specifically incorporated in such information), at no cost,
upon written or oral request to us at the following address:

Alpha Tau Medical Ltd.

Attention: VP Legal

Kiryat HaMada St. 5

Jerusalem

9777605